Korsana Biosciences, Inc. (KRSA): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2022-12-31
$6.89M2018-12-31: $3.44M2019-12-31: $6.89M2020-12-31: $1.52M2021-12-31: $7.0K2022-12-31: $0$0
2018-12-31 Capital Expenditures (USD) 2022-12-31
Period endedCapital ExpendituresChange YoYSource filing
2022-12-31$0-100.0%2023-03-22, From 2022-01-01
2021-12-31$7.0K-99.5%2023-03-22, From 2021-01-01
2020-12-31$1.52M-77.9%2022-02-24, From 2020-01-01
2019-12-31$6.89M+100.3%2021-02-25, From 2019-01-01
2018-12-31$3.44Mn/a2020-03-12, From 2018-01-01